(NEM) Nemetschek O.N. - Ratings and Ratios
BIM Software, CAD Software, 3D Modeling, Facility Management, Rendering Software
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.46% |
| Yield on Cost 5y | 0.94% |
| Yield CAGR 5y | 16.36% |
| Payout Consistency | 85.1% |
| Payout Ratio | 31.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 38.9% |
| Value at Risk 5%th | 59.8% |
| Relative Tail Risk | -6.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.27 |
| Alpha | -40.72 |
| CAGR/Max DD | 0.26 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.517 |
| Beta | 0.224 |
| Beta Downside | 0.394 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.04% |
| Mean DD | 9.23% |
| Median DD | 6.10% |
Description: NEM Nemetschek O.N. January 03, 2026
Nemetschek SE (XETRA:NEM) is a Munich-based software vendor that serves the architecture, engineering, construction, operation, and media markets worldwide. It organises its business into four segments: Design (Allplan, Graphisoft, dRofus) delivering BIM-centric CAD tools; Build (Nevaris, Blubeam) offering 5D BIM, ERP and cloud workflow solutions; Manage (Spacewell, Crem Solutions) providing property- and facility-management platforms; and Media (Maxon) supplying 3D modeling, animation and rendering software for visual-effects, product design and gaming.
In FY 2023 the group posted €1.2 bn of revenue, up 9 % YoY, with an adjusted EBITDA margin of roughly 22 %, reflecting strong demand for BIM adoption as construction firms accelerate digital transformation. The European construction market’s CAGR of ~4 % (2021-2026) and the rising ESG-driven requirement for energy-efficient building operations are key macro drivers that underpin Nemetschek’s growth prospects. Additionally, the Media segment’s 15 % YoY revenue increase highlights the expanding use of high-quality 3D visualisation in both architecture and the gaming industry.
For a deeper dive into Nemetschek’s valuation metrics and scenario analysis, you might find ValueRay’s data platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 204.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 6.17 > 1.0 |
| NWC/Revenue: -6.32% < 20% (prev -71.92%; Δ 65.60% < -1%) |
| CFO/TA 0.19 > 3% & CFO 392.5m > Net Income 204.2m |
| Net Debt (187.7m) to EBITDA (364.1m): 0.52 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.5m) vs 12m ago -0.02% < -2% |
| Gross Margin: 58.24% > 18% (prev 0.51%; Δ 5773 % > 0.5%) |
| Asset Turnover: 56.05% > 50% (prev 44.25%; Δ 11.80% > 0%) |
| Interest Coverage Ratio: 9.04 > 6 (EBITDA TTM 364.1m / Interest Expense TTM 31.9m) |
Altman Z'' (< 1.1 .. > 2.6) 2.84
| A: -0.04 (Total Current Assets 501.6m - Total Current Liabilities 574.7m) / Total Assets 2.04b |
| B: 0.41 (Retained Earnings 842.0m / Total Assets 2.04b) |
| C: 0.14 (EBIT TTM 288.6m / Avg Total Assets 2.06b) |
| D: 0.75 (Book Value of Equity 852.2m / Total Liabilities 1.14b) |
| Altman-Z'' Score: 2.84 = A |
ValueRay F-Score (Strict, 0-100) 91.12
| 1. Piotroski: 7.50pt |
| 2. FCF Yield: 3.89% |
| 3. FCF Margin: 32.73% |
| 4. Debt/Equity: 0.57 |
| 5. Debt/Ebitda: 0.52 |
| 6. ROIC - WACC: 10.13% |
| 7. RoE: 23.48% |
| 8. Revenue Trend: 94.95% |
| 9. EPS Trend: 59.30% |
What is the price of NEM shares?
Over the past week, the price has changed by -14.10%, over one month by -21.29%, over three months by -29.24% and over the past year by -31.58%.
Is NEM a buy, sell or hold?
What are the forecasts/targets for the NEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 120.3 | 61.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.8 | -6.1% |
NEM Fundamental Data Overview January 19, 2026
P/E Trailing = 46.7797
P/E Forward = 35.2113
P/S = 8.2601
P/B = 11.0654
P/EG = 1.486
Revenue TTM = 1.16b EUR
EBIT TTM = 288.6m EUR
EBITDA TTM = 364.1m EUR
Long Term Debt = 449.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 13.8m EUR (from shortTermDebt, last quarter)
Debt = 495.2m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 187.7m EUR (from netDebt column, last quarter)
Enterprise Value = 9.74b EUR (9.56b + Debt 495.2m - CCE 307.5m)
Interest Coverage Ratio = 9.04 (Ebit TTM 288.6m / Interest Expense TTM 31.9m)
EV/FCF = 25.74x (Enterprise Value 9.74b / FCF TTM 378.6m)
FCF Yield = 3.89% (FCF TTM 378.6m / Enterprise Value 9.74b)
FCF Margin = 32.73% (FCF TTM 378.6m / Revenue TTM 1.16b)
Net Margin = 17.65% (Net Income TTM 204.2m / Revenue TTM 1.16b)
Gross Margin = 58.24% ((Revenue TTM 1.16b - Cost of Revenue TTM 483.1m) / Revenue TTM)
Gross Margin QoQ = 50.67% (prev 55.89%)
Tobins Q-Ratio = 4.78 (Enterprise Value 9.74b / Total Assets 2.04b)
Interest Expense / Debt = 1.08% (Interest Expense 5.35m / Debt 495.2m)
Taxrate = 23.13% (17.0m / 73.4m)
NOPAT = 221.9m (EBIT 288.6m * (1 - 23.13%))
Current Ratio = 0.87 (Total Current Assets 501.6m / Total Current Liabilities 574.7m)
Debt / Equity = 0.57 (Debt 495.2m / totalStockholderEquity, last quarter 863.6m)
Debt / EBITDA = 0.52 (Net Debt 187.7m / EBITDA 364.1m)
Debt / FCF = 0.50 (Net Debt 187.7m / FCF TTM 378.6m)
Total Stockholder Equity = 869.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.89% (Net Income 204.2m / Total Assets 2.04b)
RoE = 23.48% (Net Income TTM 204.2m / Total Stockholder Equity 869.7m)
RoCE = 21.88% (EBIT 288.6m / Capital Employed (Equity 869.7m + L.T.Debt 449.5m))
RoIC = 16.58% (NOPAT 221.9m / Invested Capital 1.34b)
WACC = 6.45% (E(9.56b)/V(10.05b) * Re(6.74%) + D(495.2m)/V(10.05b) * Rd(1.08%) * (1-Tc(0.23)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.01%
[DCF Debug] Terminal Value 86.36% ; FCFF base≈330.7m ; Y1≈402.6m ; Y5≈664.9m
Fair Price DCF = 139.9 (EV 16.33b - Net Debt 187.7m = Equity 16.15b / Shares 115.4m; r=6.45% [WACC]; 5y FCF grow 23.23% → 2.90% )
EPS Correlation: 59.30 | EPS CAGR: 10.51% | SUE: -0.32 | # QB: 0
Revenue Correlation: 94.95 | Revenue CAGR: 12.60% | SUE: 0.61 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=-0.005 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=2.43 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=+21.5% | Growth Revenue=+13.7%